Danaher Corporation (DHR) is scheduled to release first-quarter 2024 results on Apr 23, before market open.The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.8%. In the last reported quarter, its earnings of $2.09 per share beat the consensus estimate of $1.90 by 10%.Let’s see how things have shaped up for Danaher this earnings season.Key Factors and Estimates for Q1Improving supply chains and strong price realization are expecte ...

Wall Street analysts forecast that Danaher (DHR) will report quarterly earnings of $1.72 per share in its upcoming release, pointing to a year-over-year decline of 27.1%. It is anticipated that revenues will amount to $5.64 billion, exhibiting a decline of 21.3% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimat ...

Danaher Corporation (DHR) is well poised for growth courtesy of strength across its end markets, strategic acquisitions and its focus on improving the product line and operational excellence.Image Source: Zacks Investment ResearchThe company has a market capitalization of $180.7 billion. In the past six months, the stock has gained 16.5% compared with the industry’s growth of 5.4%. DHR currently carries a Zacks Rank #2 (Buy).Let’s delve into the factors that have been aiding the firm for a while now.Busines ...

Danaher (DHR) ended the recent trading session at $244.28, demonstrating a +0.98% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 1.11%. Meanwhile, the Dow experienced a rise of 0.8%, and the technology-dominated Nasdaq saw an increase of 1.24%.The industrial and medical device maker's shares have seen a decrease of 4.81% over the last month, not keeping up with the Conglomerates sector's loss of 4.23% and the S&P 500's gain of 0.48%.The investment community will b ...

Danaher (DHR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this industrial and medical device maker have returned -3.4% over the past month versus the Zacks S&P 500 composite's +1.6% change. The Zacks Diversified Operations industry, to which Danaher belongs, has lost 3.3% over this period. Now the key question is: Where could the stock be headed in th ...

The latest trading session saw Danaher (DHR) ending at $245.94, denoting a -0.75% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.72%. At the same time, the Dow lost 1%, and the tech-heavy Nasdaq lost 0.95%.The industrial and medical device maker's shares have seen a decrease of 3.28% over the last month, not keeping up with the Conglomerates sector's gain of 2.78% and the S&P 500's gain of 2.16%.The upcoming earnings release of Danaher will be of grea ...

WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading ...

Danaher (DHR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this industrial and medical device maker have returned +0.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The Zacks Diversified Operations industry, to which Danaher belongs, has gained 6.5% over this period. Now the key question is: Where could the stock be headed in ...

Danaher (DHR) closed the most recent trading day at $251.47, moving +0.83% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Meanwhile, the Dow experienced a rise of 0.2%, and the technology-dominated Nasdaq saw an increase of 0.82%.The industrial and medical device maker's shares have seen a decrease of 0.24% over the last month, not keeping up with the Conglomerates sector's gain of 5.08% and the S&P 500's gain of 1.76%.Analysts and investors ...

Danaher Corporation (DHR) has been benefiting from strength in its Life Sciences segment driven by stable demand in the academic and life science research markets. Growth in demand for plasmids, proteins, gene writing and editing solutions augurs well for the segment.The company has been witnessing positive responses from its new products like IDBS' Polar Insight and Molecular Devices' CellXpress.ai, which help accelerate the drug discovery process and bring new therapies to market faster. Also, in the Diag ...